Capricor Therapeutics, Inc. Skyrocketed

Thu 09 Jan 20 at 05:30 PM
Capricor Therapeutics, Inc. Skyrocketed

Capricor Therapeutics, Inc. (CAPR:NASDAQ) rocketted at $1.75, a gain of 33.6%. On Wed 08 Jan 20, CAPR:NASDAQ hit a New 2-Week Intraday High of $1.42. From Tue 17 Dec 19, the stock recorded 64.29% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Capricor Therapeutics, Inc. (CAPR:NASDAQ)

Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.

Share